adriamycinol has been researched along with Bone Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cranswick, N; Desai, J; Herschtal, A; Liu, Z; Martin, J; McCowage, G; Michael, M; Nicholls, W; Orme, L; Porter, D; Seddon, B; Sivasuthan, J; Thomas, DM; Thomson, D; Underhill, C; Zacharin, M | 1 |
1 other study(ies) available for adriamycinol and Bone Neoplasms
Article | Year |
---|---|
Gender differences in doxorubicin pharmacology for subjects with chemosensitive cancers of young adulthood.
Topics: Adolescent; Adult; Age Factors; Antibiotics, Antineoplastic; Bone Neoplasms; Doxorubicin; Female; Hodgkin Disease; Humans; Models, Biological; Neoplasms; Pregnancy; Prospective Studies; Sarcoma, Ewing; Sex Characteristics; Young Adult | 2018 |